Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01552460 · ClinicalTrials.gov registry record
Brain Genomics Superstruct Project
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 61
- Enrollment target
NCT01552460: Completed study, sponsored by Massachusetts General Hospital.
NCT01552460 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 61 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01552460 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 61 participants
- Enrollment target
Study Summary
The purpose of this study is to explore the effects of genes and genetic variation on brain structure and function. Investigators at Harvard plan to explore the relationship between candidate genes that affect cognitive performance and brain structure/function. Since brain phenotypes reflect more proximal sequelae of gene activity, neuroimaging measures may show greater sensitivity than cognitive performance to measure gene effects.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 61 participants |
| Start Date | 2011-04 |
| Est. Completion | 2015-01 |
What the finished NCT01552460 record still lists
NCT01552460 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 61 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01552460 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01552460 about?
NCT01552460 is a clinical study titled "Brain Genomics Superstruct Project". The purpose of this study is to explore the effects of genes and genetic variation on brain structure and function. Investigators at Harvard plan to explore the relationship between candidate genes that affect cognitive performance and brain structure/function. Since brain phenotypes reflect more pr...
What is the current status of trial NCT01552460?
This trial is currently completed. The enrollment target is 61 participants. The study started on 2011-04. Estimated completion is 2015-01.
Who is sponsoring clinical trial NCT01552460?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04115306 · 61 participants · Phase 1
Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer
- NCT05070845 · 61 participants · Phase 2
Safety and Efficacy Study of PF-06835375 in Primary Immune Thrombocytopenia
- NCT05187832 · 61 participants · Phase 1
A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast Cancer
- NCT05269316 · 61 participants · Phase 1
Study to Evaluate IMP9064 as a Monotherapy or in Combination in Patients With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia